Goodwin Bradford S
Insider CIK 1293633 · RIGL Director · NGSX Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2021-05-19 | 2021-05-21 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2021-05-19 | 2021-05-21 | 25,000 | — | $0 | 35,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2020-05-15 | 2020-05-15 | 55,000 | — | $0 | 55,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2019-05-23 | 2019-05-24 | 55,000 | — | $0 | 55,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2018-05-17 | 2018-05-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2017-05-12 | 2017-05-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2016-05-11 | 2016-05-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2015-05-13 | 2015-05-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2014-05-21 | 2014-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2013-05-15 | 2013-05-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NGSX NeurogesX Inc | A Award deriv | 2012-06-07 | 2012-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2012-05-23 | 2012-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NGSX NeurogesX Inc | A Award deriv | 2012-02-07 | 2012-02-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NGSX NeurogesX Inc | A Award | 2012-01-31 | 2012-02-01 | 20,000 | $1.01 | $20.2K | 95,000 | SEC↗ |